NBIX
Neurocrine Biosciences, Inc.
Stock
$143.18+2.47 (+1.76%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $3.4B | +22.3% |
| Operating income | $795M | +30.6% |
| Net income | $706M | +3.3% |
| EPS | $6.82 | +2.3% |
| Free cash flow | $593M | +28.0% |
Neurocrine Biosciences, Inc.
$143.18+2.47 (+1.76%)Close Oct 2, 2026
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $3.4B | +22.3% |
| Operating income | $795M | +30.6% |
| Net income | $706M | +3.3% |
| EPS | $6.82 | +2.3% |
| Free cash flow | $593M | +28.0% |